Results 11 to 20 of about 218,733 (151)
Beat the giant: case of a giant prolactinoma during pregnancy on cabergoline [PDF]
Endocrinology, Diabetes & Metabolism Case Reports, 2018 Giant prolactinomas are a rare entity; during pregnancy, the risk for complications associated with these tumors is higher. Here, we report a case of a young woman who had an invasive, giant prolactinoma post resection with residual disease who became ...
Wael M Almistehi, Mussa H Almalki
doaj +4 more sources
Journal of Medical Case Reports, 2019 Background Dopamine agonists are the standard first-line medical therapy for prolactinoma. We report a rare case of giant prolactinoma with a first epileptic seizure due to rapid reduction of the tumor as a complication of dopamine agonist therapy.
Motofumi Koguchi +6 more
doaj +2 more sources
Giant prolactinoma, germline BRCA1 mutation, and depression: a case report
Journal of Medical Case Reports, 2018 Background Giant prolactinomas are very rare pituitary tumors that may exhibit an aggressive behavior and present with a life-threatening condition. Case presentation A 25-year-old white woman was admitted to our hospital with a headache, psychomotor ...
Rita Bettencourt-Silva +3 more
doaj +3 more sources
Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome
Case Reports in Endocrinology, 2018 Multiple endocrine neoplasia (MEN) type 1 syndrome is an autosomal dominant disorder caused by germline mutations in MEN1 gene, characterized by tumours in endocrine and nonendocrine organs.
Chandrika Jayakanthi Subasinghe +4 more
doaj +2 more sources
Giant prolactinoma with progressive cranial settling and central herniation: a case report
Journal of Medical Case ReportsBackground Giant prolactinoma (size > 4 cm) is a rare condition and accounts for less than 1% of pituitary adenomas. In even rarer cases, these lesions may involve craniocervical structures requiring surgical intervention. The present case is the largest
Taha Shahbazi +3 more
doaj +2 more sources
A clinical case of effective treatment of giant prolactinoma in patient with morbid obesity [PDF]
Ожирение и метаболизм, 2014 Numerous studies showed an association between prolactin levels and body weight, with increased prevalence of obesity in patients with prolactinomas. Recent data indicate potential positive influence of cabergoline treatment to metabolic disorders in ...
doaj +2 more sources
Giant Prolactinoma: Challenges in Management
AACE Endocrinology and DiabetesProlactinomas are the most common form of pituitary adenomas, 90% of which are microprolactinomas measuring 4 cm with a serum prolactin level of >1000 ng/mL. We report a case of giant prolactinoma causing optic nerve compression that initially responded well to cabergoline and later developed intratumoral hemorrhage requiring transsphenoidal resection ...
Sapna Sharma +2 more
openaire +4 more sources
De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
Clinical Medicine Insights: Case Reports, 2023 Dopamine agonists are the first-line treatment of prolactinomas. The risk of developing de novo psychiatric symptoms during dopamine agonist therapy is low.
Chayma Belhadj Slimane +4 more
doaj +2 more sources
Cerebrospinal fluid rhinorrhoea in young women after 6.5 years of therapy giant prolactinoma with Cabergolin [PDF]
Эндокринная хирургия, 2018 Cerebrospinal fluid (CSF) leak is a rare complication in of the prolactinomas treatment with dopamine agonists. In most cases CSF leak develops within the first three months of treatment starting.
Ludmila I. Astafyeva +8 more
doaj +3 more sources
Ten-year follow-up of a giant prolactinoma [PDF]
BMJ Case Reports, 2015 Giant prolactinomas are rare pituitary tumours of which management can be a challenge. A 28-year-old man presented with headaches, visual impairment and behavioural changes. Clinically, the patient was found to have hypogonadism and bitemporal hemianopsia.
Fernandes, V +3 more
openaire +5 more sources